Quintás-Cardama, Alfonso
Foghorn Therapeutics,
United States
2025 Rank: 36566
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1113 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36566 | 38718 |
| Total Cites | 11554 | 13210 |
| H-index | 57 | 61 |
| Hm-index | 19 | 20 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 138 | 138 |
| Number of Single+First Authored Papers | 109 | 109 |
| Total Cites to Single+First Authored Papers | 6093 | 6775 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 6961 | 7678 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9943 | 10877 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.21 |
| Self-Citation Percentage |
12.54%
|
|
Quintás-Cardama, Alfonso
TCR2 Therapeutics,
United States
2023 Rank: 35564
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1131 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35564 | 37137 |
| Total Cites | 10404 | 11964 |
| H-index | 54 | 59 |
| Hm-index | 19 | 19 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 113 | 113 |
| Number of Single+First Authored Papers | 109 | 109 |
| Total Cites to Single+First Authored Papers | 5526 | 6191 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 6291 | 6989 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8906 | 9773 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.22 |
| Self-Citation Percentage |
13.04%
|
|
Quintás-Cardama, Alfonso
TCR2 Therapeutics,
United States
2022 Rank: 35135
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1151 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35135 | 36448 |
| Total Cites | 9701 | 11208 |
| H-index | 52 | 57 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 100 | 100 |
| Number of Single+First Authored Papers | 107 | 107 |
| Total Cites to Single+First Authored Papers | 5193 | 5841 |
| Number of Single+First+Last Authored Papers | 133 | 133 |
| Total Cites to Single+First+Last Authored Papers | 5887 | 6568 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8268 | 9108 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.23 |
| Self-Citation Percentage |
13.45%
|
|
Quintás-Cardama, Alfonso
MA,
2021 Rank: 34355
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1133 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34355 | 35775 |
| Total Cites | 9329 | 10794 |
| H-index | 52 | 55 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 97 | 97 |
| Number of Single+First Authored Papers | 106 | 106 |
| Total Cites to Single+First Authored Papers | 5007 | 5637 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 5672 | 6334 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7941 | 8762 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.23 |
| Self-Citation Percentage |
13.57%
|
|
Quintás-Cardama, Alfonso
University of Texas MD Anderson Cancer Center,
United States
2020 Rank: 43932
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1360 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43932 | 45821 |
| Total Cites | 7586 | 8789 |
| H-index | 48 | 51 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 52 | 52 |
| Number of Single+First Authored Papers | 95 | 95 |
| Total Cites to Single+First Authored Papers | 4348 | 4915 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 4934 | 5526 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6435 | 7109 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.24 |
| Self-Citation Percentage |
13.69%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.